In 1993, prescriptions for asthma treatments accounted for 7% of all National Health Service prescriptions, the UK Department of Health has revealed, and the cost of these prescriptions was L350 million ($566.7 million), representing 11% of the net cost of all NHS prescriptions written during that year.
The number of prescriptions for asthma has increased by over 75% in the last decade, reports the DoH's central health monitoring unit, and general practitioner consultations with asthma patients have more than doubled.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze